Roche aims to prove life-saving benefits of aleglitazar

pharmafile | June 10, 2009 | News story | Research and Development |  Roche, diabetes 

Related Content

Roche secures CE Mark for automated latent tuberculosis blood test

Roche has received CE Mark approval for its Elecsys IGRA TB test, an automated blood …

Study to examine ways of improving diabetes care for younger adults

Researchers at Northumbria University are leading a £1.3m study aimed at helping GP practices improve …

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

Roche has expanded its global AI infrastructure with a NVIDIA AI factory, adding 2,176 high-performance …

The Gateway to Local Adoption Series

Latest content